Medical Device PMS & PMCF: Challenges & Opportunities The new 2017/745/EU Medical Device Regulations (MDR-2020) require increased emphasis on Post- Market.

Slides:

Advertisements

Similar presentations

Project Quality Plans Gillian Sandilands Director of Quality

Advertisements

Building a Cradle-to-Grave Approach with Your Design Documentation and Data Denise D. Dion, EduQuest, Inc. and Gina To, Breathe Technologies, Inc.

Drugs vs. Devices Jeng Mah & Gosford A Sawyerr Sept 16, 2005.

On the relationship between ISO/DTS29321 and ISO14971 & Japans Comments for new draft & amended clause 8 final of ISO/DTS /5/2008 JAHIS.

National Patient Safety Alerting System (NPSAS) Patient Safety Domain NHS England Publications Gateway Ref No

Development of ISO standards for AD syringes SIGN Meeting Cambodia, October 2002 Injection technologies G Gerald Verollet.

Regulatory Compliant Performance Improvement for Pharmaceutical Plants AIChE New Jersey Section 01/13/2004 Murugan Govindasamy Pfizer Inc.

Conformity Assessment Practical Implications InterAgency Committee on Standards Policy June 2007 Gordon Gillerman Conformity Assessment Advisor Homeland.

Options for Regulation and the Impact of Regulation on the Marketplace 29 November 2005 Alan Kent

© Safeguarding public health Implementing Medical Device Regulation and Maintaining Patient Safety Name Nicola Lennard Date October 2011.

© Safeguarding public health BIOABSORBABLE STENTS: REGULATORY ISSUES DR SUSANNE LUDGATE Clinical Director Medicines and Healthcare products Regulatory.

Implementation - Medical Devices. Overview Act on Medical Devices – background and overview. Surveillance - Competent authority. Directive 93/42. Directive.

Regulatory Approval of New Devices SCMR 2015 Interventional CMR Workshop Technology for Interventional cMRI Steve Wedan.

CE marking Catriona Blake Team Manager, Imaging, acute and community care.

IPhVWP Polish Presidency, Warsaw October 6 th 2011 Almath Spooner Irish Medicines Board Monitoring the outcome of risk minimisation activities.

Regulatory Overview.

CA 101 Certification and Registration ANSI Annual Conference 2002 by: Gordon Gillerman Manager Governmental Services Underwriters Laboratories

Legal Issues Impacting Clinical Trials Medical Device Clinical Trials Update June 19, 2009.

Stakeholders In Clinical Research Government and Regulatory Bodies Professor Phil Warner.

Corporate Responsibility and Third Party Relationships GSK and Contract Manufacturers James Hagan Vice President Corporate Environment, Health & Safety.

Slots/Windows of Opportunities HTA – Medical Devices Dr. Wolfgang Ecker EUnetHTA, Rome,

Quality Control and Quality Assurance. Quality Why is Quality a Concern? Gives competitive advantage Encourages return purchases Provides customer with.

Changes to the Therapeutic Goods Act and its implications Prepared by: Anna Frazer Prosthetist Hunter Prosthetics & Orthotics Service 10 th November 2006.

The Expectation Triad Healthcare Engineering Consultants Regulatory Compliance: “Ensuring that all of the required standards are being met”

ACCESS TO MEDICINES - POLICY AND ISSUES

Conducting Clinical Risk Assessments And Implementing Compliance Practices Jane L. Stratton Chiron Corporation VP/Associate General Counsel Chief Compliance.

Insert speaker name and company

UPCOMING CHANGES TO IN-VITRO DIAGNOSTICS (IVDs) AND LABORATORY DEVELOPED TESTS (LDTs) REGULATIONS Moj Eram, PhD November 5, 2015.

WORKSHOP ON ACCREDITATION OF BODIES CERTIFYING MEDICAL DEVICES INT MARKET TOPIC 9 CH 8 ISO MEASUREMENT, ANALYSIS AND IMPROVEMENT INTERNAL AUDITS.

1 From Regulatory Intelligence to Compliance Debbie Henderson Head, Global Regulatory Policy EU Ring May 13, 2014.

Department of Computer Science Introduction to Information Security Chapter 8 ISO/IEC Semester 1.

The Regulation on Cell Therapy Products in Japan

KEVIN BEDAL LISA CARLIN MATT CARROLL ERIN NICHOLS Product Safety & Failure Analysis.

rSDV offers the best alternative option to altogether reduce onsite monitoring activities, how to maintain subject privacy in the process of collecting source documents and what 21 CFR Part 11 requires, strategies for remote review of source documents at

Clusters working group COM/CAMD New Regulations

Environmental, Health and Safety Leader (m/f)

FDA's Two New Draft Guidance on Software and Device

CA 101 Certification and Registration

CPA Gilberto Rivera, VP Compliance and Operational Risk

Regulation of Medical Devices: Importance of a Globally Harmonized Approach Nicole Taylor Smith, JD September 2017.

Report on OIML Seminar on Conformity to Type (CTT): Utrecht June 2011

Analysis of Current Maturity Models and Standards

Patient Focused Drug Development An FDA Perspective

IAEA C2G Working Group 1 (Import / Export Controls, Repatriation, and National inventories / Registries) Outcome / Recommendation Summary Paul Gray & Dariusz.

Growing need of Clinical Data, PMCF & Registries for Devices Post Market Clinical Follow Up (PMCF) studies are a critical component of the clinical evidence.

Nicole Denjoy COCIR Secretary General

How to Apply for and Receive Industry Funding for Investigator Sponsored Research Chuck Simonton MD, FACC, FSCAI Chief Medical Officer Abbott Vascular.

Multichannel Learning System: Research Protocol Strategy

DIA Clinical Safety and Pharmacovigilance Community

Reasonable Assurance of Safety and Effectiveness: An FDA Division of Cardiovascular Devices Perspective Bram Zuckerman, MD, FACC Director, FDA Division.

Preventing Medical Device Recalls

Analysis of the Proposed Sunshine Rule: Legal Considerations

Gluten – Free Labelling with a Special Focus on Fermented, Hydrolyzed or Distilled Foods: How to Prove & Display It Correctly Webinar Details Date : September.

DDi is organizing the webinar on Vendor/CRO Oversight How effectively are you doing?. This webinar is planned to focus on vendor oversight plan, as well as strategies by identifying critical elements required and also aligning proper techniques of risk ma

MakroCare is organizing the webinar on Importance & Requirements of Clinical Evaluation for CER. This webinar is planned to focus on ensuring that clinical data are evaluated in a systematic and objective way, that the benefit/risk profile is acceptable a

MakroCare is organizing the webinar on Device Registries as PMCF tools. This webinar will provide an overview of PMCF requirements, outline elements of a well-designed registry and offer advice about known, potential pitfalls.

Risk Management EU MDR Perspective Risk management is understood as a continuous iterative process throughout the entire lifecycle of a device, requiring.

State Beef Council Reviews Monitoring of QSBC expenditure compliance

Accreditation in National Quality Infrastructure; Challenges & Opportunities Mr. Sanath P Mendis National Quality Policy Expert, UNIDO, Eu-Sri Lanka Trade.

Quality Control SOP 3.12 Release Date: 08/10/2015.

Beyond Academia.

Quality and Regulatory Planning – the way forward?

A Practical Introduction to the Clinical Evaluation Report

Medical Device Design and Development

ISO management systems

Evidence standards for device approval: Regulatory perspectives

MEDICAL DEVICES CONTROL SYSTEM IN INDONESIA

Research, Experimentation, & Clinical Trials

Role of KMLTTB in HIV POC implementation

HealthCare Artificial Intelligence

Presentation transcript:

Medical Device PMS & PMCF: Challenges & Opportunities The new 2017/745/EU Medical Device Regulations (MDR-2020) require increased emphasis on Post- Market Clinical Follow-Up (PMCF) as a part of clinical evaluation to demonstrate conformity to safety and performance of devices. Many device manufacturers are unaccustomed to conducting post- marketing clinical studies and tend to regard study activity as both costly and time-intensive. Proper design, planning and execution of PMCF studies are essential to ensure return on investments. This webinar will focus on pitfalls and challenges in planning, conducting, and managing PMCF studies. It will discuss approaches that can be utilized to optimize resources and mitigate risk. The webinar will cover the following topics: Protocol development to support business needs Study conduct in compliance with ISO:14155 Collecting safety data Centralized monitoring Tools consideration.

About Our Speaker Mary Majer Clinical Subject Matter Expert, Medical Devices Register here: for-medical-device-pms-pmcf-challenges-opportunitieshttps:// for-medical-device-pms-pmcf-challenges-opportunities